Free Beta: Procurement discovery is free; verify every opportunity on SAM.gov. Source status
Award noticeAwarded

Advance the development of SCY-247, a novel antifungal currently in Phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and IC formula

HEALTH AND HUMAN SERVICES, DEPARTMENT OF › OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE › BARDA - ASPR / DAAPPO / BARDA DCMA

AwardAwarded to Scynexis, Inc.
View official notice on SAM.gov (opens in a new tab)
Verify before acting. Users must verify deadlines, amendments, attachments, eligibility, and submission requirements on the official SAM.gov notice. Read the Data Disclaimer.

Key decision factors

Awardee
Scynexis, Inc.
Award amount
$213943726.00
Award date
Sep 25, 2026
Award number
75A50126C00007
Notice type
Award Notice
Set-aside
Not provided or not applicable
NAICS
Not provided by SAM.gov
PSC
Not provided by SAM.gov
Place of performance
Jersey City, New Jersey
Current status
Awarded

Notice details

Official status
Awarded
Normalized group
Award notice
Notice ID
5d2b1c5f6d094d72ad9916f20fc33ed3
Solicitation number
BAA-23-100-SOL-00004

Description

Full description is not currently available in MaroNest. Review the official SAM.gov notice for complete requirements.

Attachments

No attachments were reported for this notice. MaroNest reflects only what the source data reports — review the official SAM.gov notice (opens in a new tab) to confirm whether related documents or amendments exist.

Contacts

Audrey Glover
Primary
audrey.glover@hhs.gov
Veronica Stroud
Secondary
veronica.stroud@hhs.gov

Personalized relevance

Would this fit your company?

Create company profile information with a free account to see a deterministic, explainable relevance score. Matching does not determine eligibility or win probability.

Create Free Account

Pursuit risk (separate from your match score)

No major pursuit restriction detected

We did not detect a major source or competition restriction in the information analyzed. This is not an eligibility determination.

Pursuit risk is evaluated separately from your match score above and never changes it. This is not a legal or eligibility determination — verify against the official SAM.gov notice and attachments.

Award information

Award number
75A50126C00007
Award date
Sep 25, 2026
Amount
$213943726.00
Awardee
Scynexis, Inc.
Awardee UEI
Not provided
Awardee location
Jersey City, NJ 07302, USA